Lista de obras - Gene S Tan - Dominio Público Uruguay

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates

artículo científico publicado en 2012

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

artículo científico publicado en 2012

A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

artículo científico publicado en 2012

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

artículo científico publicado en 2017

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

artículo científico publicado en 2015

Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus

article

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

artículo científico publicado en 2014

Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.

artículo científico publicado en 2010

Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection

artículo científico publicado en 2020

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

artículo científico publicado en 2016

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

artículo científico publicado en 2014

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

artículo científico publicado en 2010

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

artículo científico publicado en 2017

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

artículo científico publicado en 2016

Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin

artículo científico publicado en 2014

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.

artículo científico publicado en 2016

Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.

artículo científico publicado en 2015

Divergent H7 immunogens offer protection from H7N9 virus challenge.

artículo científico publicado en 2014

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

artículo científico publicado en 2016

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity

artículo científico publicado en 2008

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

artículo científico publicado en 2015

Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice

artículo científico publicado en 2012

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

artículo científico publicado en 2012

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

artículo científico publicado en 2013

Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein

scientific article published on 28 June 2019

Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model

artículo científico publicado en 2018

In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies

artículo científico publicado en 2013

Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins

artículo científico publicado en 2016

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

artículo científico publicado en 2012

Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1

artículo científico publicado en 2019

Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers

artículo científico publicado en 2009

Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection

artículo científico publicado en 2020

Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein

artículo científico publicado en 2020

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

artículo científico publicado en 2020

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

artículo científico publicado en 2016

PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity

artículo científico publicado en 2008

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.

artículo científico publicado en 2015

Rabies virus nucleoprotein as a carrier for foreign antigens.

artículo científico publicado en 2004

Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.

artículo científico publicado en 2009

Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime–boost approach

article

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice

artículo científico publicado en 2017

The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.

artículo científico publicado en 2005

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

artículo científico publicado en 2010

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

artículo científico publicado en 2015

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses

artículo científico publicado en 2015

Lista de obras de Gene S Tan

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.

Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.

Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein

Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model

In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies

Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1

Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers

Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection

Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.

Rabies virus nucleoprotein as a carrier for foreign antigens.

Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.

Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime–boost approach

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice

The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses